AC
Annandale Capital Portfolio holdings
AUM $542M
1-Year Return
10.03%
This Quarter Return
+7.12%
1 Year Return
+10.03%
3 Year Return
+43.01%
5 Year Return
–
10 Year Return
–
AUM
$442M
AUM Growth
+$13.3M
(+3.1%)
Cap. Flow
-$23.3M
Cap. Flow
% of AUM
-5.27%
Top 10 Holdings %
Top 10 Hldgs %
42.67%
Holding
137
New
8
Increased
26
Reduced
36
Closed
9
Top Buys
| 1 |
Dimensional US Core Equity 1 ETF
DCOR
|
+$2.42M |
| 2 |
Dimensional International Core Equity Market ETF
DFAI
|
+$2.22M |
| 3 |
Avantis US Equity ETF
AVUS
|
+$2.2M |
| 4 |
Baidu
BIDU
|
+$2.06M |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$2.04M |
Top Sells
| 1 |
Antero Resources
AR
|
+$21.3M |
| 2 |
3M
MMM
|
+$5.95M |
| 3 |
Dollar General
DG
|
+$4.98M |
| 4 |
Meta Platforms (Facebook)
META
|
+$4.41M |
| 5 |
SPDR S&P Regional Banking ETF
KRE
|
+$4.27M |
Sector Composition
| 1 | Communication Services | 12.07% |
| 2 | Financials | 10.8% |
| 3 | Consumer Discretionary | 7.79% |
| 4 | Energy | 6.84% |
| 5 | Technology | 6.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Westwater Resources
WWR
$57.9M
| $123K | 0.02% |
250,000
-50,000
| -17% | -$24.6K |
|
127
Ryan Specialty Holdings
RYAN
$6.56B
| $72K | 0.01% |
15,000
| – | – |
|
|
APTO
128
DELISTED
Aptose Biosciences, Inc.
APTO
| $44K | 0.01% |
889
-1,600
| -64% | -$79.2K |
|
129
Antero Midstream
AM
$8.86B
| – | – |
-98,800
| Closed | -$1.24M |
|
130
Cullinan Oncology
CGEM
$376M
| – | – |
-12,000
| Closed | -$122K |
|
131
Charles River Laboratories
CRL
$7.53B
| – | – |
-7,900
| Closed | -$1.87M |
|
132
Cue Biopharma
CUE
$56.8M
| – | – |
-65,000
| Closed | -$172K |
|
|
133
Dollar General
DG
$23B
| – | – |
-36,627
| Closed | -$4.98M |
|
134
Danaher
DHR
$135B
| – | – |
-2,600
| Closed | -$601K |
|
|
ELEV
135
DELISTED
Elevation Oncology
ELEV
| – | – |
-50,000
| Closed | -$27K |
|
|
136
3M
MMM
$83.2B
| – | – |
-65,114
| Closed | -$5.95M |
|
137
Xeris Biopharma Holdings
XERS
$1.2B
| – | – |
-55,820
| Closed | -$131K |
|